STAT+: PACT Pharma’s personalized cancer treatments, powered by CRISPR, clear early safety hurdles

November 10, 2022 San Francisco Biotechnology Network News News Comments Off on STAT+: PACT Pharma’s personalized cancer treatments, powered by CRISPR, clear early safety hurdles
PACT Pharma and UCLA researchers infused individualized cocktails of CRISPR-edited immune cells into 16 cancer patients with minimal and manageable side effects.

Click to view original post

Related Articles

No Picture
News

STAT+: Pharmalittle: Biden picks biotech exec to lead new biomedical research agency; FDA to hold meeting for OTC birth control pill

September 13, 2022 San Francisco Biotechnology Network News News Comments Off on STAT+: Pharmalittle: Biden picks biotech exec to lead new biomedical research agency; FDA to hold meeting for OTC birth control pill

President Biden named biologist and former DARPA scientist Renee Wegrzyn as the first director of the Advanced Research Projects Agency for Health. […]